Analysts Set Pliant Therapeutics, Inc. (NASDAQ:PLRX) PT at $13.31
Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have earned an average rating of “Hold” from the twelve ratings firms that are presently covering the company, Marketbeat reports. Twelve research analysts have rated the stock with a hold recommendation. The average 1 year target price among analysts that have covered the stock in […]
Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have earned an average rating of “Hold” from the twelve ratings firms that are presently covering the company, Marketbeat reports. Twelve research analysts have rated the stock with a hold recommendation. The average 1 year target price among analysts that have covered the stock in […]
